Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HE9J
|
||||
Former ID |
DIB002919
|
||||
Drug Name |
APN-201
|
||||
Synonyms |
Lipoxysan; Liposomal SOD (wound healing), Polymun; Liposomal SOD (Peyronie's disease), Polymun; RhSOD (liposomal, dermatitis), Apeiron; Liposomal superoxide dismutase (recombinant, encapsulated, topical), Polymun
|
||||
Indication | Dermatitis [ICD9: 692.9; ICD10:L20-L30] | Phase 1/2 | [523766] | ||
Company |
Polymun Scientific Immunobiologische Forschung GmbH
|
||||
Target and Pathway | |||||
Target(s) | Superoxide dismutase [Cu-Zn] | Target Info | Modulator | [525361] | |
BioCyc Pathway | Reactive oxygen species degradation | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Validated nuclear estrogen receptor alpha network | ||||
FOXA1 transcription factor network | |||||
PathWhiz Pathway | Degradation of Superoxides | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.